Japan · Nation Thailand
Sunmax Launches Premium Porcine Collagen in Thailand for ASEAN Expansion
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
By prioritizing strict patient safety and scientific innovation over commercial hype, the company is positioning the country as its ultimate regional launchpad to redefine the medical aesthetics industry across the broader ASEAN region.
Key facts
- Within the Asia-Pacific landscape, excluding China, Thailand proudly ranks as the second-largest aesthetics center directly behind Korea, making it highly attractive for premium medical launches in 2026
- He elaborated that the company spent 25 years becoming the world leader in collagen aesthetics, and for the next 25 years, they want to stay on top, keep improving the science, and give patients safe, natural-looking results everywhere.
- Instead of relying on traditional marketing strategies based on fleeting trends, the Vanguard partnership focuses intensely on peer-to-peer (P2P) training sessions to ensure that Thai physicians can use the product competently
- The core competitive advantage of Sunmax Biotech lies in its uniquely developed premium collagen, Deusaderm, which fundamentally differs from traditional aesthetic products currently available on the market
Summary
PR news
The core competitive advantage of Sunmax Biotech lies in its uniquely developed premium collagen, Deusaderm, which fundamentally differs from traditional aesthetic products currently available on the market. The company utilizes a specific pathogen-free (SPF) porcine source, raised in highly secure clean rooms in Taiwan, which ensures the extracted material is strictly medical-grade rather than standard food-grade.